310 related articles for article (PubMed ID: 34408783)
1. Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Xu X; Yang Y; Zhou G; Du Z; Zhang X; Mao W; Cai H
Evid Based Complement Alternat Med; 2021; 2021():9761159. PubMed ID: 34408783
[TBL] [Abstract][Full Text] [Related]
2. Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis.
Xiang Q; Wang M; Ding Y; Fan M; Tong H; Chen J; Yu P; Shen L; Chen X
Front Pharmacol; 2022; 13():832782. PubMed ID: 35444529
[No Abstract] [Full Text] [Related]
3. Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis.
Sun J; Zhang K; Xiong WJ; Yang GY; Zhang YJ; Wang CC; Lai L; Han M; Ren J; Lewith G; Liu JP
BMC Complement Altern Med; 2016 Jul; 16():201. PubMed ID: 27402016
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials.
Wei J; Li B; Wang X; Li X; Hu Y; Qiao L; Zhou C; Yu P; Sang T; Zhu M; Wang Y
Front Pharmacol; 2022; 13():893602. PubMed ID: 35571117
[No Abstract] [Full Text] [Related]
5. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
[TBL] [Abstract][Full Text] [Related]
6. [Network Meta-analysis of Chinese patent medicine in treatment of heart failure with preserved ejection fraction].
Tian J; Xu BR; Xing ZY; Qiu BY; Si CY; Zhu MJ; Wang YX
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):819-835. PubMed ID: 38621886
[TBL] [Abstract][Full Text] [Related]
7. [Comparative analysis of clinical effects according to syndrome differentiation of Qili Qiangxin Capsules on ischemic heart failure: Meta-analysis].
Sun YL; Ruan XF; Li YP; Wang XL
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4975-4984. PubMed ID: 31872608
[TBL] [Abstract][Full Text] [Related]
8. [Network Meta-analysis of 11 Chinese patent medicines in treatment of dilated cardiomyopathy].
Wang ZX; Wang H; Ban JF; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6778-6797. PubMed ID: 38212037
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Chen W; Chang H; Wang X; Wang Y; Liu Y; Wang D
Evid Based Complement Alternat Med; 2023; 2023():2701314. PubMed ID: 36777628
[TBL] [Abstract][Full Text] [Related]
10. [Network Meta-analysis of six Chinese patent medicines for replenishing Qi and activating blood in treatment of chronic heart failure].
Park YS; Wang W; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4221-4237. PubMed ID: 36046913
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews.
Lin SS; Liu CX; Zhang JH; Wang XL; Mao JY
Evid Based Complement Alternat Med; 2020; 2020():8620186. PubMed ID: 32908572
[TBL] [Abstract][Full Text] [Related]
12. Effect of Traditional Chinese Medicine Cutaneous Regions Therapy as adjuvant treatment of chronic heart failure: A systematic review and meta-analysis.
Li M; Li H; Liu H; Lai X; Xing W; Shang J
Heliyon; 2023 May; 9(5):e16012. PubMed ID: 37206004
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of Qili Qiangxin Capsule combined with exercise rehabilitation in the treatment of chronic heart failure.
Zhu M; Chen L; Xu Z; Xi X; Shi X; Zhang Y
Explore (NY); 2023; 19(3):445-449. PubMed ID: 36307314
[TBL] [Abstract][Full Text] [Related]
14. Qili Qiangxin (QLQX) capsule as a multi-functional traditional Chinese medicine in treating chronic heart failure (CHF): A review of ingredients, molecular, cellular, and pharmacological mechanisms.
Wang T; Hou B; Qin H; Liang J; Shi M; Song Y; Ma K; Chen M; Li H; Ding G; Yao B; Wang Z; Wei C; Jia Z
Heliyon; 2023 Nov; 9(11):e21950. PubMed ID: 38034785
[TBL] [Abstract][Full Text] [Related]
15. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
[TBL] [Abstract][Full Text] [Related]
16. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
Mei J; Xu H; Xu FQ; Ju JQ
Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
[TBL] [Abstract][Full Text] [Related]
17. [Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis].
Liu HM; Wang XB; Chang YJ; Gu LL
Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1211-28. PubMed ID: 23158939
[TBL] [Abstract][Full Text] [Related]
18. Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism.
Xing X; Guo J; Mo J; Li H; Zhang H; Shao B; Wang Y; Li H; Wang J; Leung CL; Jiang Y; Yin W; Chen H; He Q
Front Cardiovasc Med; 2022; 9():1090616. PubMed ID: 36712277
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction.
Xiao J; Deng SB; She Q; Li J; Kao GY; Wang JS; Ma YU
Exp Ther Med; 2015 Nov; 10(5):1817-1823. PubMed ID: 26640555
[TBL] [Abstract][Full Text] [Related]
20. [Guizhi Fuling capsule / pill treatment for chronic pelvic inflammatory disease：a systematic review of randomized clinical trials].
Zhang LS; Yang FW; Zhang JH; Zheng WK; Zhang MY; Li Y; Zhao HJ
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1500-1509. PubMed ID: 29071853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
